drugset / Trial / NCT02202213
Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of Lu AF11167 in patients with schizophrenia following various repeated dosing regimens of Lu AF11167 (alone or as added treatment to risperidone).
Timeline
- Start
- 2013-10
- Primary completion
- 2015-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF11167 | Unknown | 0.25 mg | Oral |
| Subject | Lu AF11167 | Unknown | 0.5 mg | Oral |
| Subject | Lu AF11167 | Unknown | 1 mg | Oral |